CA2863788A1 - Compositions and methods for monitoring biometric indicators - Google Patents
Compositions and methods for monitoring biometric indicators Download PDFInfo
- Publication number
- CA2863788A1 CA2863788A1 CA2863788A CA2863788A CA2863788A1 CA 2863788 A1 CA2863788 A1 CA 2863788A1 CA 2863788 A CA2863788 A CA 2863788A CA 2863788 A CA2863788 A CA 2863788A CA 2863788 A1 CA2863788 A1 CA 2863788A1
- Authority
- CA
- Canada
- Prior art keywords
- fluorescent
- injectate
- hematocrit
- marker
- optical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 53
- 238000012544 monitoring process Methods 0.000 title abstract description 11
- 239000000203 mixture Substances 0.000 title description 5
- 238000005534 hematocrit Methods 0.000 claims abstract description 160
- 239000003550 marker Substances 0.000 claims abstract description 130
- 230000002792 vascular Effects 0.000 claims abstract description 56
- 230000003068 static effect Effects 0.000 claims abstract description 37
- 210000004369 blood Anatomy 0.000 claims abstract description 33
- 239000008280 blood Substances 0.000 claims abstract description 33
- 238000009826 distribution Methods 0.000 claims abstract description 23
- 238000012937 correction Methods 0.000 claims abstract description 20
- 230000024924 glomerular filtration Effects 0.000 claims abstract description 8
- 230000003287 optical effect Effects 0.000 claims description 108
- 239000000523 sample Substances 0.000 claims description 50
- 230000005284 excitation Effects 0.000 claims description 41
- 241000894007 species Species 0.000 claims description 15
- 210000000214 mouth Anatomy 0.000 claims description 10
- 230000000087 stabilizing effect Effects 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 5
- 230000000737 periodic effect Effects 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims 6
- 238000005259 measurement Methods 0.000 abstract description 8
- 238000012360 testing method Methods 0.000 description 24
- 238000011088 calibration curve Methods 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 210000005166 vasculature Anatomy 0.000 description 6
- 230000001419 dependent effect Effects 0.000 description 5
- 239000007850 fluorescent dye Substances 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 4
- 238000009534 blood test Methods 0.000 description 4
- 239000012482 calibration solution Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229920002521 macromolecule Polymers 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 238000004611 spectroscopical analysis Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000002238 attenuated effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 208000020832 chronic kidney disease Diseases 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001268 conjugating effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000036757 core body temperature Effects 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000002249 decongestive effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000005055 memory storage Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000006213 oxygenation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000000541 pulsatile effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 239000001022 rhodamine dye Substances 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0082—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
- A61B5/0088—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes for oral or dental tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14535—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring haematocrit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/20—Measuring for diagnostic purposes; Identification of persons for measuring urological functions restricted to the evaluation of the urinary system
- A61B5/201—Assessing renal or kidney functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/6813—Specially adapted to be attached to a specific body part
- A61B5/6814—Head
- A61B5/682—Mouth, e.g., oral cavity; tongue; Lips; Teeth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dentistry (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Urology & Nephrology (AREA)
- Audiology, Speech & Language Pathology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Physiology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261600182P | 2012-02-17 | 2012-02-17 | |
| US61/600,182 | 2012-02-17 | ||
| PCT/US2013/026277 WO2013123285A1 (en) | 2012-02-17 | 2013-02-15 | Compositions and methods for monitoring biometric indicators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2863788A1 true CA2863788A1 (en) | 2013-08-22 |
Family
ID=48984726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2863788A Abandoned CA2863788A1 (en) | 2012-02-17 | 2013-02-15 | Compositions and methods for monitoring biometric indicators |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20140369936A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3207873A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2015510436A (cg-RX-API-DMAC7.html) |
| CN (2) | CN104244826A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013221451A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2863788A1 (cg-RX-API-DMAC7.html) |
| IN (1) | IN2014DN06772A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013123285A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013221451A1 (en) * | 2012-02-17 | 2014-08-21 | Pharmacophotonics, Inc. | Compositions and methods for monitoring biometric indicators |
| WO2015061680A1 (en) | 2013-10-24 | 2015-04-30 | Pharmacophotonics, Inc. D/B/A Fast Biomedical | Compositions and methods for optimizing the detection of fluorescent signals from biomarkers |
| US20180180622A1 (en) * | 2015-06-24 | 2018-06-28 | Pharmacophotonics, Inc. D/B/A Fast Biomedical | Method and apparatus for determining biometric indicators using multiple fluorescent markers |
| KR102306048B1 (ko) * | 2017-01-30 | 2021-09-29 | 메디비콘 아이엔씨. | 확산 반사 보정을 갖는 형광 추적제의 비침습 모니터링 방법 |
| CN111902075A (zh) * | 2018-01-16 | 2020-11-06 | 梅约医学教育与研究基金会 | 快速评估肾功能的系统和方法 |
| HUE071082T2 (hu) * | 2018-06-08 | 2025-08-28 | Revvity Health Sciences Inc | Többspektrális elemzõ rendszerek kalibrálása |
| US11946865B2 (en) * | 2018-06-28 | 2024-04-02 | Becton, Dickinson And Company | Systems and methods for normalizing signals in blood culture measurement systems |
| JP2022504413A (ja) * | 2018-10-05 | 2022-01-13 | ファーマコフォトニクス，インコーポレイティド，ディー／ビー／エー ファスト バイオメディカル | 間隙体積を決定するための方法及び装置 |
| WO2020264295A1 (en) * | 2019-06-28 | 2020-12-30 | Procisedx Inc. | Methods for accommodating for sample matrix effects in light measurement assays |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5341805A (en) * | 1993-04-06 | 1994-08-30 | Cedars-Sinai Medical Center | Glucose fluorescence monitor and method |
| JPH11192207A (ja) * | 1997-11-07 | 1999-07-21 | Matsushita Electric Ind Co Ltd | ビデオスコープおよび携帯収納ケース |
| GB9810471D0 (en) * | 1998-05-16 | 1998-07-15 | Helmet Hund Gmbh | Toothbrush |
| JP2001008893A (ja) * | 1999-06-29 | 2001-01-16 | Toshiyuki Abe | 口腔テレビカメラのプローブ |
| US6440389B1 (en) * | 2000-07-19 | 2002-08-27 | The General Hospital Corporation | Fluorescent agents for real-time measurement of organ function |
| US20060178556A1 (en) * | 2001-06-29 | 2006-08-10 | Intuitive Surgical, Inc. | Articulate and swapable endoscope for a surgical robot |
| EP1433456A4 (en) * | 2001-09-12 | 2007-05-30 | Terumo Corp | MEDICATION CONTAINERS AND MEDICATION INJECTION DEVICE CONTAINING THEM |
| EP1620002B1 (en) * | 2003-04-24 | 2012-01-04 | The Board Of Regents, The University Of Texas System | Noninvasive blood analysis by optical probing of the veins under the tongue |
| DE102004024494B4 (de) * | 2004-05-16 | 2019-10-17 | Dürr Dental SE | Medizinische Kamera |
| US7796243B2 (en) * | 2004-06-09 | 2010-09-14 | National Research Council Of Canada | Detection and monitoring of changes in mineralized tissues or calcified deposits by optical coherence tomography and Raman spectroscopy |
| US7440788B2 (en) * | 2004-08-26 | 2008-10-21 | Kelvyn Enterprises, Inc. | Oral health measurement clamping probe, system, and method |
| AU2006236407B2 (en) | 2005-04-19 | 2011-04-28 | Indiana University Research And Technology Corporation | Method and apparatus for kidney function analysis |
| US7386333B1 (en) * | 2005-04-29 | 2008-06-10 | Henryk Birecki | Test subject monitoring device |
| GB0718291D0 (en) * | 2007-09-19 | 2007-10-31 | King S College London | Imaging apparatus and method |
| US20100268090A1 (en) * | 2007-11-06 | 2010-10-21 | Rubinstein Eduardo H | Measurement of hematocrit and cardiac output from optical transmission and reflection changes |
| US9746471B2 (en) * | 2008-01-25 | 2017-08-29 | Multivir Inc. | P53 biomarkers |
| US8591865B2 (en) | 2008-04-18 | 2013-11-26 | Pharmacophotonics, Inc. | Renal function analysis method and apparatus |
| CA2721846C (en) * | 2008-04-18 | 2021-01-26 | Pharmacophotonics, Inc. | Renal function analysis method and apparatus |
| WO2010009335A1 (en) * | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
| CA2760511A1 (en) | 2009-04-30 | 2010-11-04 | Pharmacophotonics, Inc. | Measurement of body fluid volumes |
| US8187002B2 (en) * | 2010-06-29 | 2012-05-29 | Mcneil-Ppc, Inc. | Method for cleaning the oral cavity |
| GB201011913D0 (en) * | 2010-07-15 | 2010-09-01 | Lux Innovate Ltd | Detecting device |
| AU2013221451A1 (en) * | 2012-02-17 | 2014-08-21 | Pharmacophotonics, Inc. | Compositions and methods for monitoring biometric indicators |
-
2013
- 2013-02-15 AU AU2013221451A patent/AU2013221451A1/en not_active Abandoned
- 2013-02-15 WO PCT/US2013/026277 patent/WO2013123285A1/en not_active Ceased
- 2013-02-15 EP EP17164592.2A patent/EP3207873A1/en not_active Ceased
- 2013-02-15 CA CA2863788A patent/CA2863788A1/en not_active Abandoned
- 2013-02-15 CN CN201380019079.6A patent/CN104244826A/zh active Pending
- 2013-02-15 IN IN6772DEN2014 patent/IN2014DN06772A/en unknown
- 2013-02-15 US US14/374,259 patent/US20140369936A1/en not_active Abandoned
- 2013-02-15 CN CN201810162169.5A patent/CN108261183A/zh active Pending
- 2013-02-15 EP EP13749013.2A patent/EP2814393B1/en not_active Not-in-force
- 2013-02-15 JP JP2014557798A patent/JP2015510436A/ja active Pending
-
2017
- 2017-11-29 US US15/825,823 patent/US20180256755A9/en not_active Abandoned
-
2018
- 2018-03-01 JP JP2018036525A patent/JP2018102959A/ja active Pending
-
2020
- 2020-05-28 JP JP2020093506A patent/JP2020163170A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3207873A1 (en) | 2017-08-23 |
| JP2018102959A (ja) | 2018-07-05 |
| CN108261183A (zh) | 2018-07-10 |
| EP2814393B1 (en) | 2017-04-05 |
| JP2015510436A (ja) | 2015-04-09 |
| AU2013221451A1 (en) | 2014-08-21 |
| US20180147302A1 (en) | 2018-05-31 |
| JP2020163170A (ja) | 2020-10-08 |
| EP2814393A1 (en) | 2014-12-24 |
| US20180256755A9 (en) | 2018-09-13 |
| US20140369936A1 (en) | 2014-12-18 |
| WO2013123285A1 (en) | 2013-08-22 |
| EP2814393A4 (en) | 2015-10-14 |
| CN104244826A (zh) | 2014-12-24 |
| IN2014DN06772A (cg-RX-API-DMAC7.html) | 2015-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2814393B1 (en) | Compositions and methods for monitoring biometric indicators | |
| US20220214349A1 (en) | Method and apparatus for determining biometric indicators using multiple fluorescent markers | |
| MIller et al. | Performance of an in-vivo, continuous blood-gas monitor with disposable probe. | |
| EP2725967B1 (en) | An apparatus for optical analysis of an associated tissue sample | |
| JP6506275B2 (ja) | 改善された経皮臓器機能測定 | |
| EP3733066B1 (en) | Method of measuring a concentration of a gaseous substance, a gas sensor apparatus and a method of calibrating a gas sensor | |
| Witthauer et al. | Portable oxygen-sensing device for the improved assessment of compartment syndrome and other hypoxia-related conditions | |
| US20160256574A1 (en) | Method and apparatus for kidney function analysis | |
| Martin et al. | Performance and use of paracorporeal fiber optic blood gas sensors | |
| Ergin et al. | The feasibility of real-time in vivo optical detection of blood–brain barrier disruption with indocyanine green | |
| US20200174018A1 (en) | Method and apparatus for determining interstitial volume | |
| HK40059402A (en) | Method and apparatus for determining interstitial volume | |
| WO2023039129A1 (en) | Method and apparatus for monitoring plasma volume | |
| JP2006158611A (ja) | インドシアニングリーン定量カテーテルシステム | |
| Schlain et al. | Continuous blood gas monitoring in femoral arteries | |
| Verdeccchia et al. | Multi-Distance Depth-Resolved Diffuse Correlation Spectroscopy | |
| EP3865854A1 (en) | Calibration of a sensor | |
| Baldini et al. | Biomedical fibre-optics sensors and systems for in-vivo applications | |
| Mignani et al. | Fiber optic sensors in health care | |
| Divers et al. | Continuous intra-arterial blood-gas monitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180215 |
|
| FZDE | Discontinued |
Effective date: 20230208 |
|
| FZDE | Discontinued |
Effective date: 20230208 |